Abstract
Synthesis of double-stranded DNA from the retrovirus (+)-strand RNA genome is a multi-step process catalyzed by the virus-coded reverse transcriptase (RT), using a combination of synthetic (RNA- and DNA-dependent DNA synthesis) and degradative activities (ribonuclease H, or RNase H). For human immunodeficiency virus type 1 (HIV-1) RT, the two-subunit p66/p51 heterodimer must accommodate a variety of conformationally distinct nucleic acid substrates, including duplex RNA, RNA/DNA hybrids duplex DNA, and RNA-DNA chimeras to complete this process (Telesnitsky and Goff 1997). Despite a wealth of structural and biochemical studies, the mechanism whereby RT adopts different orientations to coordinate its DNA polymerase and RNase H activities has remained elusive. The lower processivity of HIV-1 RT (Bibillo and Eickbush 2002) also raises the issue of polymerization site targeting when the enzyme re-engages its nucleic acid substrate distal from the primer terminus. Although X-ray crystallography has contributed significantly to our understanding of reverse transcription complexes and resistance to antiviral drugs, it provides a static picture, revealing few details regarding motion of the enzyme on its substrate. In contrast, single-molecule spectroscopy has proven an invaluable tool capable of resolving static and dynamic heterogeneity of an ensemble (Lu et al. 1998; Moerner and Orrit 1999; Weiss 2000). In an early study, (Rothwell et al. 2003) used a fluorescence resonance energy transfer (FRET) approach to distinguish three structurally distinct HIV-1 RT species, including one form where nucleic acid was positioned to permit nucleotide incorporation and a second corresponding to a nucleoprotein complex formed following nucleotide addition but prior to translocation. However, since this seminal study, little progress has been made in dissection of the conformational dynamics of reverse transcription. Progress in these areas and the implications for investigational and established inhibitors that interfere with HIV-1 RT function will be reviewed here.
Conflict of interest statement: None declared
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- Cy3:
-
Cyanine 3
- Cy5:
-
Cyanine 5
- ddNTP:
-
Dideoxynucleoside triphosphate
- dNTP:
-
Deoxynucleoside triphosphate
- FRET:
-
Fluorescence resonance energy transfer
- HIV:
-
Human immunodeficiency virus
- LTR:
-
Long terminal repeat
- MLV:
-
Murine leukemia virus
- NC:
-
Nucleocapsid protein
- NNRTI:
-
Nonnucleoside RT inhibitor
- PPT:
-
Polypurine tract
- RSV:
-
Rous sarcoma virus
- RT:
-
Reverse transcriptase
- UTR:
-
Untranslated region
References
Abbondanzieri EA, Bokinsky G, Rausch JW, Zhang JX, Le Grice SF, Zhuang X (2008) Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453(7192):184–189
Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA (2008) Strand transfer events during HIV-1 reverse transcription. Virus Res 134(1–2):19–38
Beerens N, Berkhout B (2002) The tRNA primer activation signal in the human immunodeficiency virus type 1 genome is important for initiation and processive elongation of reverse transcription. J Virol 76(5):2329–2339
Beerens N, Groot F, Berkhout B (2001) Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem 276(33):31247–31256
Bibillo A, Eickbush TH (2002) High processivity of the reverse transcriptase from a non-long terminal repeat retrotransposon. J Biol Chem 277(38):34836–34845 [Research Support, U.S. Gov’t, P.H.S.]
Carpousis AJ, Gralla JD (1980) Cycling of ribonucleic acid polymerase to produce oligonucleotides during initiation in vitro at the lac UV5 promoter. Biochemistry 19(14):3245–3253
Chapman KB, Bystrom AS, Boeke JD (1992) Initiator methionine tRNA is essential for Ty1 transposition in yeast. Proc Natl Acad Sci USA 89(8):3236–3240
Charneau P, Alizon M, Clavel F (1992) A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 66(5):2814–2820 [Comparative Study Research Support, Non-U.S. Gov’t]
Croxtall JD (2012) Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection. Drugs 72(6):847–869 [Review]
Das K, Martinez SE, Bauman JD, Arnold E (2012) HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat Struct Mol Biol 19(2):253–259 [Research Support, N.I.H., Extramural]
Dash C, Scarth BJ, Badorrek C, Gotte M, Le Grice SF (2008) Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids. Nucleic Acids Res 36(20):6363–6371 [Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov’t]
Grobler JA, Dornadula G, Rice MR, Simcoe AL, Hazuda DJ, Miller MD (2007) HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro. J Biol Chem 282(11):8005–8010 [In Vitro]
Huang Y, Wang J, Shalom A, Li Z, Khorchid A, Wainberg MA et al (1997) Primer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1. J Virol 71(1):726–728 [Research Support, Non-U.S. Gov’t]
Huang H, Chopra R, Verdine GL, Harrison SC (1998) Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282(5394): 1669–1675
Huber HE, McCoy JM, Seehra JS, Richardson CC (1989) Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching. J Biol Chem 264(8):4669–4678 [Comparative Study Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Isel C, Ehresmann C, Keith G, Ehresmann B, Marquet R (1995) Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J Mol Biol 247(2):236–250
Isel C, Westhof E, Massire C, Le Grice SF, Ehresmann B, Ehresmann C et al (1999) Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J 18(4):1038–1048
Jacobo-Molina A, Ding J, Nanni RG, Clark AD Jr, Lu X, Tantillo C et al (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 a resolution shows bent DNA. Proc Natl Acad Sci USA 90(13):6320–6324
Jakobsen MR, Haasnoot J, Wengel J, Berkhout B, Kjems J (2007) Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology 4:29 [Research Support, Non-U.S. Gov’t]
Ji X, Klarmann GJ, Preston BD (1996) Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35(1):132–143 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Kim JH, Larson RG (2007) Single-molecule analysis of 1D diffusion and transcription elongation of T7 RNA polymerase along individual stretched DNA molecules. Nucleic Acids Res 35(11):3848–3858 [Research Support, U.S. Gov’t, Non-P.H.S.]
Kim S, Schroeder CM, Xie XS (2010) Single-molecule study of DNA polymerization activity of HIV-1 reverse transcriptase on DNA templates. J Mol Biol 395(5):995–1006 [In Vitro Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]
Lanchy JM, Ehresmann C, Le Grice SF, Ehresmann B, Marquet R (1996a) Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J 15(24):7178–7187
Lanchy JM, Isel C, Ehresmann C, Marquet R, Ehresmann B (1996b) Structural and functional evidence that initiation and elongation of HIV-1 reverse transcription are distinct processes. Biochimie 78(11–12):1087–1096
Le Grice SF, Naas T, Wohlgensinger B, Schatz O (1991a) Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J 10(12):3905–3911
Le Grice SF, Panin M, Kalayjian RC, Richter NJ, Keith G, Darlix JL et al (1991b) Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase. J Virol 65(12):7004–7007 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Leis J (1993) Regulation of initiation of reverse transcription of retroviruses. In: Skalka AM, Goff SP (eds) Reverse transcriptase. Cold Spring Harbor Laboratory Press, Plainview, pp. 33–48
Levin JG, Seidman JG (1979) Selective packaging of host tRNA’s by murine leukemia virus particles does not require genomic RNA. J Virol 29(1):328–335
Liu S, Abbondanzieri EA, Rausch JW, Le Grice SF, Zhuang X (2008) Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science 322(5904):1092–1097 [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov’t]
Liu S, Harada BT, Miller JT, Le Grice SF, Zhuang X (2010) Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription. Nat Struct Mol Biol 17(12):1453–1460 [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural]
Lu HP, Xun L, Xie XS (1998) Single-molecule enzymatic dynamics. Science 282(5395):1877–1882 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S.]
Metzger W, Hermann T, Schatz O, Le Grice SF, Heumann H (1993) Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes. Proc Natl Acad Sci U S A 90(13):5909–5913 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Miller JT, Khvorova A, Scaringe SA, Le Grice SF (2004) Synthetic tRNALys, 3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes. Nucleic Acids Res 32(15):4687–4695 [Comparative Study]
Moerner WE, Orrit M (1999) Illuminating single molecules in condensed matter. Science 283(5408):1670–1676 [Research Support, U.S. Gov’t, Non-P.H.S. Review]
Quan Y, Liang C, Inouye P, Wainberg MA (1998) Enhanced impairment of chain elongation by inhibitors of HIV reverse transcriptase in cell-free reactions yielding longer DNA products. Nucleic Acids Res 26(24):5692–5698
Rausch JW, Le Grice SF (1997) Substituting a conserved residue of the ribonuclease H domain alters substrate hydrolysis by retroviral reverse transcriptase. J Biol Chem 272(13):8602–8610 [Research Support, U.S. Gov’t, P.H.S.]
Rausch JW, Le Grice SF (2004) ‘Binding, bending and bonding’: polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol 36(9):1752–1766 [Review]
Rausch JW, Le Grice SF (2007) Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res 35(1):256–268 [Research Support, N.I.H., Intramural]
Rausch JW, Grice MK, Henrietta M, Nymark M, Miller JT, Le Grice SF (2000a) Interaction of p55 reverse transcriptase from the Saccharomyces cerevisiae retrotransposon Ty3 with conformationally distinct nucleic acid duplexes. J Biol Chem 275(18):13879–13887 [Research Support, U.S. Gov’t, P.H.S.]
Rausch JW, Sathyanarayana BK, Bona MK, Le Grice SF (2000b) Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site-specific photocross-linking. J Biol Chem 275(21):16015–16022 [Research Support, U.S. Gov’t, P.H.S.]
Rodriguez-Rodriguez L, Tsuchihashi Z, Fuentes GM, Bambara RA, Fay PJ (1995) Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J Biol Chem 270(25):15005–15011 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Rothwell PJ, Berger S, Kensch O, Felekyan S, Antonik M, Wohrl BM et al (2003) Multiparameter single-molecule fluorescence spectroscopy reveals heterogeneity of HIV-1 reverse transcriptase: primer/template complexes. Proc Natl Acad Sci U S A 100(4):1655–1660 [Research Support, Non-U.S. Gov’t]
Sarafianos SG, Das K, Tantillo C, Clark AD Jr, Ding J, Whitcomb JM et al (2001) Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA: DNA. EMBO J 20(6):1449–1461
Tanese N, Goff SP (1988) Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc Natl Acad Sci U S A 85(6):1777–1781 [Research Support, U.S. Gov’t, P.H.S.]
Taylor JM, Illmensee R (1975) Site on the RNA of an avian sarcoma virus at which primer is bound. J Virol 16(3):553–558
Telesnitsky A, Goff SP (1997) Reverse transcriptase and the generation of retroviral DNA. In: Coffin JM, Hughes SH, Varmus HE (eds) Retroviruses. Cold Spring Harbor Laboratory Press, Plainview
Turner KB, Brinson RG, Yi-Brunozzi HY, Rausch JW, Miller JT, Le Grice SF et al (2008) Structural probing of the HIV-1 polypurine tract RNA: DNA hybrid using classic nucleic acid ligands. Nucleic Acids Res 36(8):2799–2810 [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, U.S. Gov’t, Non-P.H.S.]
Wagner J, Nohmi T (2000) Escherichia coli DNA polymerase IV mutator activity: genetic requirements and mutational specificity. J Bacteriol 182(16):4587–4595 [Research Support, Non-U.S. Gov’t]
Weiss S (2000) Measuring conformational dynamics of biomolecules by single molecule fluorescence spectroscopy. Nat Struct Biol 7(9):724–729 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Review]
Wendeler M, Lee HF, Bermingham A, Miller JT, Chertov O, Bona MK et al (2008) Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity. ACS Chem Biol 3(10):635–644 [Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural]
Whiting SH, Champoux JJ (1994) Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase. J Virol 68(8):4747–4758 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]
Williams KJ, Loeb LA, Fry M (1990) Synthesis of DNA by human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(deoxyadenosine) tracts. J Biol Chem 265(30):18682–18689 [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]
Wu W, Henderson LE, Copeland TD, Gorelick RJ, Bosche WJ, Rein A et al (1996) Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol 70(10):7132–7142 [Research Support, U.S. Gov’t, P.H.S.]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
LeGrice, S.F.J. (2013). Conformational Dynamics of Reverse Transcription. In: LeGrice, S., Gotte, M. (eds) Human Immunodeficiency Virus Reverse Transcriptase. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7291-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7291-9_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7290-2
Online ISBN: 978-1-4614-7291-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)